Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due 2020

LAVAL, Quebec, April 12, 2018 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) (“Valeant”) today announced that Valeant Pharmaceuticals International, a…

You must be a paid subscriber to view this content. To become a new paid subscriber, please go to the REGISTER TAB and choose one of the subscription plans.

error: Content is protected !!
en_USEnglish
en_USEnglish